You are here

Development of the TrueTissue Platform for Non-lethal Weapon Testing and Evaluation

Award Information
Agency: Department of Defense
Branch: Army
Contract: W91CRB-20-C-0036
Agency Tracking Number: A2-8120
Amount: $1,099,997.63
Phase: Phase II
Program: SBIR
Solicitation Topic Code: A15-029
Solicitation Number: 15.1
Solicitation Year: 2015
Award Year: 2020
Award Start Date (Proposal Award Date): 2020-03-12
Award End Date (Contract End Date): 2022-09-08
Small Business Information
301 1st Street SW Suite 200
Roanoke, VA 24011-1921
United States
DUNS: 627132913
HUBZone Owned: No
Woman Owned: No
Socially and Economically Disadvantaged: No
Principal Investigator
 Matthew DeWitt
 (434) 220-7692
Business Contact
 Maggie Hudson
Phone: (434) 220-1551
Research Institution

Non-lethal weapons (NLWs), including less-lethal kinetic energy impact munitions, are designed to incapacitate or repel targets with non-penetrating wounds and a low probability of fatality or permanent injury. Rapid market growth has created an intensely competitive effort to develop and commercialize more effective and safer NLWs. Although the benefits of impact munitions are numerous, concern for the deleterious effects that the munitions have on the target when penetration occurs remains. In fact, there have been over 2000 reported penetrating injuries ranging from minor to significant and over 50 deaths from impact munitions in the past 30 years. Unfortunately, NLW safety research and evaluation standards are limited by a lack of universally accepted test protocols or materials to determine the lethality of non-penetrating NLWs with statistical rigor and ensure safe use. To address the critical need for more reliable safety of NLWs and advancement of kinetic energy impact munitions, Luna Innovations is leading the development of TrueTissue, a ballistic testing platform for NLWs.

* Information listed above is at the time of submission. *

US Flag An Official Website of the United States Government